| (azilsartan medoxomil and chlorthalidone)
[Drug information / PDF]
Dosing: Click (+) next to Dosage and Administration section (drug info link)
ABBREVIATED MONOGRAPH – SEE PACKAGE INSERT.
Initial U.S. Approval: 2011
When pregnancy is detected, discontinue EDARBYCLOR as soon as possible (5.1)
INDICATIONS AND USAGE
In patients not adequately controlled with monotherapy (1)
Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions (1)
Dose may be increased to 40/25 mg after 2 to 4 weeks as needed to achieve blood pressure goals.
Maximal dose is 40/25 mg.
May be administered with other antihypertensive agents.
DOSAGE FORMS AND STRENGTHS
WARNINGS AND PRECAUTIONS
|Adult (usual) Hypertension (HTN): initial, 1 tab (50 mg losartan/12.5 mg HCTZ) po qd. HTN: titration, allow 3 wk to achieve optimum antihypertensive effect. HTN: titrate to maintenance, may increase to MAX dose of 100/50 mg orally once daily.
Supplied: (50 mg/12.5 mg, 100 mg/25 mg)
(Diovan HCT ®)
|Adult (usual) Hypertension: initial, 12.5 HCTZ/80 mg valsartan orally once daily. Hypertension: maintenance 12.5/80 mg to 25/160 mg po qd. Titrate at intervals of 3-4 wekks. MAX 25/160 mg daily.
Supplied: (80 mg/12.5 mg, 160 mg/12.5 mg, 160mg/25 mg)
National Institutes of Health, U.S. National Library of Medicine, DailyMed Database.
Provides access to the latest drug monographs submitted to the Food and Drug Administration (FDA). Please review the latest applicable package insert for additional information and possible updates. A local search option of this data can be found here.
The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user’s use of or reliance upon this material.PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read the disclaimer